Needless to say, this is a topic the researchers tackled
Reimbursement Is Getting Better Insurance coverage for GLP-1 weight-loss medications is expanding rapidly : Many commercial insurers now cover Wegovy, Saxenda, and Mounjaro with prior authorization (typically requiring BMI 30 or 27 with comorbidity) Medicare will begin covering anti-obesity medications in 2026 a game-changer for providers seeing older patients State Medicaid programs are adding coverage (varies by state, but momentum is strong) For the clinical visit itself : Bill standard E/M codes (99213-99215 for follow-ups, 99202-99205 for new patients) Psychiatrists get 100% of Medicare physician fee schedule (~$75-150 per visit depending on complexity) PMHNPs typically get 85% of physician rates for Medicare (though some state Medicaid programs like Illinois pay NPs at 100%) Telehealth parity laws in CA, NY, IL, and many other states ensure equal reimbursement for video visits Typical visit economics : 15-20 minute medication management follow-up: $100-150 reimbursement Initial evaluation (45 min): $200-250 If you see 4 weight management patients per day (1 hour total), thats $400-600 in revenue Compare that to traditional psychiatric med management (already your bread and butter) its the same billing model, just applied to a different clinical problem
youll pay for amenities you may never use
What is the difference between CPT 96372 and CPT 96401
While no tanning pills are approved by the FDA, lycopene and astaxanthin arent even marketed (and therefore are likely not being tested) for skin darkening and they definitely arent providing any protection against the sun
